Tuberculosis (TB) is an infectious disease caused by the Mycobacterium tuberculosis (M. tuberculosis) complex, resposible for health problems in developing countries. In Africa, various medicinal plants are traditionally used to treat TB. The aim of this study is to carry out the phytochemical screening, to evaluate the antimycobacterial activity of the crude extracts of three medicinal plants present i n Cameroon (Zingiber officinale, Vitellaria paradoxa and Alstonia boonei) and the acute toxicity of hydroethanolic extract of Vitellaria paradoxa. The phytochemical screening was obtained by hydroethanolic extraction and decoction. Inhibitory parameters of antimycobacterial activities were determined using the microplate alamar blue assay against M. tuberculosis H37Rv (ATCC 27294) and on one M. tuberculosis clinical strain. The crude extract with the best antimycobacterial activity was used for the acute toxicity assessment according to the OECD proto col. The results of the phytochemical screening revealed the presence of triterpenes and steroids in all the extracts, whereas phenols were only present in the decoction of Alstonia boonei. All extracts tested showed antimycobacterial activities. The hydroethanolic extract of V. paradoxa presented the best antimycobacterial activity with MICs of 78.13 and 625 μg/mL and MBCs of 78.13 and 2500 μg/mL respectively on M. tuberculosis H37Rv and on M. tuberculosis clinical strain. The results of the acute toxicity evaluation of V. paradoxa showed a lethal dose 50 greater than 5000 mg/kg compared to control. The antimycobacterial activity of all the plant extracts used in this study justifies the traditional use of these medicinal plants on the treatment of TB.
INTRODUCTION
Mycobacterium tuberculosis (M. tuberculosis), the leading causative agent of tuberculosis (TB) is responsible for the morbidity and mortality of a large population worldwide 1 . It is widespread in poor countries, with more than 80% of cases occurring in Asia and Africa 2 . TB does not exhibit any symptom of disease except when impairment of immunity arises due to malnutrition, diabetes, malignancy and AIDS 3 ; however, about 10% of healthy individuals may develop active TB in their life time due to genetic factors.
The ability of TB to resist drugs and the influence of HIV epidemy has made the disease remain a devastating global public health problem 4 . In 2016, an estimated number of 10.4 million new TB infections were reported, on which 90% were adults, 65% were male and 10% were people living with HIV 5. This disease is responsible for approximately two million deaths annually 6 . The alarming rise of multidrug-resistant (MDR), extensively drug-resistant (XDR) and currently, totally drug resistant (TDR) M. tuberculosis strains, which are difficult to control with the currently available essential antitubercular drugs on the market, and the increased incidence of TB associated with viral infections such as HIV, have recently complicated the chemotherapeutics of TB 7. Indeed, the side effects of current anti-TB drugs used in long course in combination for the treatment of disease, lead to poor patient compliance and thus promoting the emmergence of resistant strains 8 . As a result, one of the current lines of research is the investigation of new natural compound endowed with antimycobaterial properties and non toxic, which can permit to fight effectively both susceptible and resistant strains of M. tuberculosis. Natural products of plant biodiversity have received considerable attention as potential anti-TB agents since they are proven templates for the development of new molecules against TB. Many antitubercular compounds that may prove to be useful leads for TB drug discovery have been derived from medicinal plants 9 .
In Africa, many plants are used against various respiratory tract infections, including: Zingiber officinale (Zingiberaceae) 10 , Vitellaria paradoxa (Sapotaceae) 10, 11, 12 and Alstonia boonei (Apocynaceae) 13, 14 . Numerous scientific studies have shown that these plants have various biological properties 15, 16, 17 , but very few have investigated the antimycobacterial properties of Zingiber officinale and Vitellaria paradoxa and so far to the best of our knowledge, no study has been carried out on extracts of Alstonia boonei.
Ginger (Z. officinale) in Cameroon is traditionally used in the villages of the Central Region for the treatment of respiratory diseases 18 and in the Littoral region, for the treatment of infectious disorders, such as pulmonary infections including TB 14 . In Niger, it is used in the treatment of TB and other respiratory diseases 10 . Shea tree (V. paradoxa) is traditionally used in Cameroon against intestinal worms in children 19 , while in Niger it is used for the treatment of TB and other respiratory diseases 10 and in the states of Bauchi and Ogun in Nigeria for the treatment of TB 11, 12 . As for "devil tree " (A. boonei) 20 , it is traditionally used for the treatment of endocrino-metabolic, neurological, cardiovascular and infectious disorders such as pulmonary infections and TB 14 . In Kisangani, Congo (Zaire), it is used against throat diseases and TB 13 . However in traditional medicine, the method of preparation commonly used for the use of these plants is the decoction 18 . The purpose of the present study, however, is to carry out the phytochemical screening, determine the antimycobacterial activity and evaluate the acute toxicity of crude extracts obtained by hydroethanolic extraction (30° ethanol) and decoction of Zingiber officinale, Vitellaria paradoxa and Alstonia boonei.
MATERIALS AND METHODS

Chemicals
Rifampicin (Rif) were obtained from Sigma-Aldrich (St. Quentin Fallavier, France). Stock solutions at 1000 μg/mL were filter sterilized and stored at -20°C. Working solutions were prepared at four times the final higher concentration in Middlebrook 7H9 supplemented with 2% glycerol, 10% OADC (oleic acid, albumin, dextrose, and catalase) and 0.05% (vol/vol) Tween 40 (Sigma). Alamar blue dye 0.01% (weight/volume) from Sigma-Aldrich (St. Quentin Fallavier, France) was prepared and sterilized by filtration, and stored at 4°C for up to 1 week. Kit SGM Italia were also obtained from Sigma-Aldrich.
Collection and extraction of plant materials
Fresh rhizomes of Z. officinale were purchased in August 2017 from three Markets (Mvog-beti, Mokolo and Acacia), Yaoundé, Center Region, Cameroon. The stem bark of V. paradoxa and A. boonei were harvested respectively in September 2017 from Tcholliré village, North Region, Cameroon and in August 2017 from Kala village, Center Region, Cameroon. Botanical identification of the plants was performed at the Cameroon National Herbarium, where the voucher specimens were conserved under the reference numbers 14757/SRF/Cam (Z. officinale), 14591/SRF/Cam (V. paradoxa) and 1943/SRFK (A. boonei).
The fresh rhizomes of Z. officinale after being purchased in the different markets were washed with tap water and then cut and dried at room temperature away from light. The barks of V. paradoxa and A. boonei after harvest were directly cut and dried at room temperature away from light. Once well dried, they were finely crushed manually using mortar and pestle to obtain a powder. The extracts were obtained by two common extraction techniques, maceration and decoction.
According to maceration, The extracts were prepared as earlier described by combination of Prakash et al. (2005) 21 and Sourabie et al. (2012) 22 with slight modifications. One hundred and fifty grams of each powder were soaked with 750 mL of 30% ethanol in ratio 1:5 (w/v) and mixed intermittently for 48h. This process was repeated three times and subsequently, the suspension was filtered using Whatman No.1 filter paper. The filtrate obtained was concentrated using a rotary evaporator at 79°C, the residue was lyophilized and stored at room temperature.
The extracts obtained by decoction were prepared as earlier described by Sourabie et al. (2012) 22 with slight modifications. A total of 1000 mL of boiling distilled water was poured into 150 g of plant powder under constant shaking with magnetic stirrer for 15 min. This operation was repeated twice and at the end of the extraction, it was filtered through nylon mesh followed by Whatman filter paper No.1. The filtrate was then concentrated under reduced pressure on rotary evaporator at 40°C, the residue was lyophilized and stored at room temperature.
Experimental animals
Albino Wistar rats aged 8 to 12 weeks old, weighing between 125 g to 169 g were obtained from the animal house, of the Department of Animal Biology and Physiology, University of Yaounde I, Cameroon. They were allowed to acclimatize for a period of 2 weeks. They were maintained in clean metabolic cage-sand, placed in a wellventilated room conditions with a temperature of 26ºC to 28ºC, photoperiods of 12 hours light and 12 hours darkness; humidity of 40% to 60% (Rong et al., 2009) 23 .
Phytochemical screening
The various plant extracts were screened for plant metabolites using the lyophilized materials. It was carried out in accordance with standard methods described by Harbone (1998) 24 and Evans (2000) 25 . These metabolites include alcaloid, phenols, polyphenols, tanins, saponins, flavonoids, triterpens, steroids, anthocyanins and anthraquinones.
In vitro antimycobacterial assay
Bacterial strains and growth conditions
The studied microbial species included two strains of mycobacteria, namely, a drug-susceptible strain of M. tuberculosis H37Rv (ATCC 27294) and one M. tuberculosis clinical strain (MTCS). They were maintained on Lowenstein-Jensen (LJ) slopes and cultured on Middlebrook 7H9 broth supplemented. Cultures were grown aerobically on supplemented broth medium at 37°C.
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Microplate alamar blue assay (MABA)
All samples were tested against M. tuberculosis using the microplate dilution method 26 . The MIC and MBC of all samples against M. tuberculosis strains were tested using the MABA according to Collins and Franzblau, 1997 27 . Briefly, representative colonies of M. tuberculosis from Lowenstein-Jensen (LJ) slope were suspended in 1 mL distilled water and the turbidity was adjusted to match McFarland tube No.1 (10 7 CFU/mL) and further diluted to 1:25 in Middlebrook 7H9 broth supplemented and used as inoculums. One hundred microliters of Middlebrook 7H9 broth supplemented was dispensed in each well of a sterile flat-bottom 96-well plate, and serial twofold dilutions of the crude extracts and each positive control drug were prepared directly in the plate. One hundred microliters of inoculum was added to each well. A growth control and a sterile control were also included for each mycobacterial strain. Sterile water was added to all perimeter wells to avoid evaporation during incubation. The plates were covered, sealed in plastic bags, and incubated at 37°C under a normal atmosphere. After incubation for about 7 days, 20 µL of Alamar blue solution were added to the wells. The plates were re-incubated overnight at the same temperature. A color change from blue to pink indicated bacterial growth. All experiments were carried out in triplicate. The minimum inhibitory concentration (MIC) was defined as the lowest concentration of the crude extract or positive control drug that prevented this change in color and the minimum bactericidal concentration (MBC) corresponded to the minimum concentration of extract that did not produce a shift in cultures re-incubated in fresh medium. The classification of the extracts was made by calculating the ratio MBC/MIC as described by Carbonelle et al. (1987) 28 and Gatsing et al. (2006) 29 for which, an antimicrobial substance is considered bactericidal when the ratio MBC/MIC ≤ 4 and bacteriostatic when the ratio MBC/MIC ˃4.
Toxicity test
Acute toxicity study
Acute toxicity study was performed according to the procedures outlined by the Organization for Economic Co-operation and Development guidelines 423 30 . Twelve Wistar female albino rats were used for this study. The rats were randomly divided into 3 groups of 4 animals each, with the first group as the control. The hydroethanolic extract of V. paradoxa was administered to rats in groups 2 and 3 in single oral doses of 2000 mg/kg and 5000 mg/kg body weight respectively, by intra gastric gavage using oral cannula. The control group (Group 1) received an equal volume of distilled water. Observations of toxic symptoms were made and recorded within the first hour, four hours and subsequently for 24 hours after administration of the extract. Behavioral parameters and mortality were also monitored closely for 14 days. Lethal dose in 50 % of the total population (LD50) was interpolated using OECD method 30 .
Body weight
The rats in all the groups were weighed using a sensitive balance, before starting the administration of extract, every two days during the observation period and once on the day of sacrifice. Doses of the extract administered were adjusted accordingly.
Relative organ weight
On day 14 of the observation period, all the animals were euthanised by exsanguination under chloroform anesthesia. The rats were later sacrificed through lumbar dislocation. Different organs namely the kidneys, liver, spleen, lungs and heart were carefully dissected out and weighed in grams (absolute organ weight). The relative organ weight of each animal was then calculated as follows:
Biochemical analyses
Blood samples were collected from the animals through cardiac puncture, into clean and dry tubes. The blood collected was allowed to clot and then centrifuged at 5000 rpm for 10 minutes. The serum was separated and kept frozen at -4ºC until required for analysis (Aniagu et al., 2005) 23 . The separated clear sera collected were used for the biochemical assays of AST, ALT and Creatinin using SGM Italia reagent kit.
Statistical analysis
The experimental results were expressed as the Mean ± S.E.M. Statistical significant difference in parameters amongst groups was determined by One way ANOVA followed by Tukey's multiple range test using GraphPad version 7.0. P<0.05 was considered to be significant.
RESULTS AND DISCUSSION
The extraction yields and the physical properties of the various extracts obtained by hydroethanol maceration and decoction are recorded in Table I . These yields ranging from 5.97 to 13.63% respectively for V. paradoxa bark and Z. officinale rhizomes for maceration. Meanwhile, in decoction they ranging from 2.36 to 27.77% respectively for A.boonei bark and Z. officinale rhizomes. For two (02) of the three (03) samples, the extraction yield obtained by decoction is greater than that obtained by hydroethanol maceration for a similar sample. These results corroborate those of Mahmoudi et al. (2013) 31 and Lehout and Laib (2015) 32 , who made the same observation in their work. However, for A.boonei bark, the extraction yield by hydroethanol maceration was higher than that of the decoction. This reduction in the extraction yield of A. boonei by decoction would probably be due to the denaturation of certain thermosensitive compounds by heat, as presented by the work of Kémajou et al. (2012) 33 , who evaluated the influence of drying temperature on the active ingredients (total alkaloids) of A. boonei; where they found that the total alkaloids content of the bark extract gradually decreases as the drying temperature increases. In addition, rhizomes of Z. officinale had the best extraction yield, both in hydroethanol maceration and decoction. This observation could be explained by the fact that rhizomes of Z. officinale contain more active compounds. It is in the same light that the work of Mariangela et al. (2015) 34 , demonstrated that in addition to the pulp of rhizomes of Z. officinale, the skin of this latter also contains active compounds and that it contains more non-polar compounds and even twice as many polyphenolic compounds as the pulp. In fact, according to Bruneton (1999) 35 the extraction yields of the plants are different depending on the species of the plant, the organ and the extraction solvent. The determination of the extraction yield makes it possible to assess the total extract of each species and organ of the plant thus making it possible to estimate the quantity of the part of the plant to be harvested if necessary to allow the rational use of these plant species 36 .
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[99] CODEN (USA): JDDTAO The results of the phytochemical screening of the extracts are shown in Table II . From this phytochemical test, it is seen that all the extracts contain triterpenes and steroids, and that among these extracts, only the decoction of A. boonei contains phenols. This could be explained by the fact that during extraction, the heat produced during the decoction would have caused the breaking of certain bonds, thus causing the formation of phenols. This is in line with results obtained by Ross et al. (2011) 37 who reported that under the effect of high temperature, there is partial degradation of lignin, leading to the release of phenolic acid derivatives. Amongst other things, saponins would probably be sensitive to heat because their presence is considerably reduced, or even absent in decoction compared to maceration in all samples. Alkaloids, saponins, flavonoids and steroids present in Z. officinale extract have also been reported in the work of Kobo et al. (2014) 38 . Amongst others, Amari (2016) 39 51 showed that, depending on the polarity of the extraction solvents, the metabolites present in the extracts differ in their polarity and structure and hence, the antimicrobial activities of the compounds extracted from plants changes with a change in structure. It is in this sense that Cowan (1999) 52 alluded to the example between catechol and pyrogallol, both of which are hydroxylated phenols that have been shown to be toxic to microorganisms. Catechol has two hydroxyl groups and pyrogallol has three hydroxyl groups. The site (s) and number of groups on the aromatic ring are thought to be related to their relative toxicity to microorganisms, with evidence that increased hydroxylation leads to increased toxicity. In addition, some authors have found that more strongly oxidized phenols are more inhibitory 52 . It also appears from the results of this work that, in general, the hydroethanolic extracts were more active than those obtained by decoction on the two strains. Nevertheless, despite the fact that extracts obtained by decoction generally contain with more chemical compounds due to their high yield, they are still less active than hydroethanolic extracts. This could be explained by the difference in concentration of active ingredients in plant extracts 53 . Indeed, decoction despite their high yield contain a low concentration of active ingredients with antimycobacterial properties, compared to extracts obtained by hydroethanolic maceration, which for their low yield contain a large number of compounds with antimycobacterial properties. This low decoction activity can also be explained by the fact that the antimycobacterial activity of the compounds in these extracts would be masked by other compounds present in the extract 54 . According to Kuete (2010) 55 the activity of plant extracts can be classified on the basis of MICs obtained in antimicrobial tests. Thus, it can be: significant (MIC <100 μg/mL), moderate (100 <MIC <625 μg/mL) or low (MIC> 625 μg/mL). In this rank of idea, among the hydroethanolic extracts, the activity was significant for the bark of V. paradoxa (MIC = 78.13 μg/mL), moderate for the bark of A. boonei (MIC = 156 μg/mL) and low for rhizomes of Z. officinale (MIC = 1250 μg/mL) on M. tuberculosis H37Rv. In addition, with decocts on M. tuberculosis H37Rv, the activity was significant for the bark of V. paradoxa (MIC = 78.13 μg/mL), low for the bark of A. boonei and rhizomes of Z. officinale (respectively at MICs of 2500 and 5000 μg/mL). On the other hand, on the clinical strain of M. tuberculosis, the activity of hydroethanolic extracts was moderate for bark of V. paradoxa (MIC = 625 μg/mL) and low for all other extracts (with MICs of 2500 and 5000 μg/mL respectively for A. boonei and Z. officinale in hydroethanolic maceration while in decoction, MICs were 1250, 5000 and 10,000 μg/mL respectively for V. paradoxa, A. boonei and Z. officinale). Seen these results, this clinical isolate would probably be resistant. Indeed, by observing MIC obtained on this isolate with the reference anti-TB drug (Rifampicin), which was 3.91 μg/mL this result goes in the same line as that of Gordien et al. The hydroethanolic extract of V. paradoxa had the best antimycobacterial activity on both strains. The results of the acute toxicity evaluation of this extract revealed that the single administration of the 2000 and 5000 mg/kg doses of this extract to healthy female rats caused no evidence of apparent toxicity after the first 4 hours. It had no effect on the behavior of the animals (mobility, appearance of the coat, aspect of the buttocks, eye colors, ...) in comparison with the control. In addition, no deaths were noted in the experimental groups after 14 days of study. This suggests that the lethal dose 50 (LD50) of this extract would be greater than 5000 mg/kg and that this latter would be classified according to the Globally Harmonized Classification System (GHS) to category 5 of low or no toxic substances 62 . These results are similar to those obtained by Mainasara et al. (2016a) 63 who also showed that the LD50 of the methanolic extract of V. paradoxa bark was greater than 5000 mg/kg. Figure 1 illustrates the effects of the hydroethanolic extract of V. paradoxa on the weight variation of the rats. It shows that animal body weights increased exponentially the first two days after treatment, then varied irregularly until the fourteenth day for all test groups and sensibly in a regular manner for the normal group. However, no significant difference in weight was observed between the animals treated with this extract at doses of 2000 and 5000 mg/kg and the control. In the same rank of idea, Mainasara et al. (2016b) 64 demonstrated by their work that the chronic administration of methanolic extract of V. paradoxa at doses up to 400 mg/kg for 30 days did not result in a significant variation in the weight of the rats during the period of treatment. The relative weight of the kidneys, liver, spleen, lungs and heart of the animals that received this extract after a 14-day follow-up is summarized in Figure 2 
CONCLUSION
The results of this study highlights the importance to be given to plants, since they have many properties including antimycobacterial. The antimycobacterial potential and the non-toxicity of hydroethanolic extract (ethanol 30°) of the bark of V. paradoxa justifies the traditional use of this plant for the treatment of TB. However, given the fact that M. tuberculosis H37Rv was particularly sensitive to extracts of V. paradoxa and A. boonei (respectively strong and moderate activities), these plants are excellent candidates for the search for new molecules that can act against M. tuberculosis H37Rv. 
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